Post-ischemic treatment with cannabidiol prevents electroencephalographic flattening, hyperlocomotion and neuronal injury in gerbils

被引:55
作者
Braida, D
Pegorini, S
Arcidiacono, MV
Consalez, GG
Croci, L
Sala, M
机构
[1] Univ Milan, Fac Sci, Dept Pharmacol Chemotherapy & Med Toxicol, I-20129 Milan, Italy
[2] San Raffaele Sci Inst, I-20132 Milan, Italy
关键词
global ischemia; neuroprotection; motor activity; temperature; natural cannabinoid;
D O I
10.1016/S0304-3940(03)00569-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The potential activity of cannabidiol, a non-psychoactive constituent of marijuana, in preventing damage caused by cerebral ischemia was studied. Cannabidiol (1.25-20 mg/kg) was given 5 min after 10 min bilateral carotid occlusion in freely-moving awake gerbils. Seven days after ischemia, it antagonized the electroencephalographic flattening of total spectral power, with a dose-dependent bell-shaped curve; the neuroprotective effect was greatest with 5 mg/kg. One day after ischemia cannabidiol completely antagonized ischemia-induced hyperlocomotion, at all doses. Rectal temperature did not change during the first hour after occlusion. Histological examination showed complete survival of CA1 neurons in cannabidiol-treated gerbils. These findings suggest a potential therapeutic role of cannabidiol in cerebral ischemia, though the clear mechanism of action remains to be elucidated. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:61 / 64
页数:4
相关论文
共 20 条
  • [1] The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice
    Al-Hayani, A
    Wease, KN
    Ross, RA
    Pertwee, RG
    Davies, SN
    [J]. NEUROPHARMACOLOGY, 2001, 41 (08) : 1000 - 1005
  • [2] Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
    Bisogno, T
    Hanus, L
    De Petrocellis, L
    Tchilibon, S
    Ponde, DE
    Brandi, I
    Moriello, AS
    Davis, JB
    Mechoulam, R
    Di Marzo, V
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (04) : 845 - 852
  • [3] Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system
    Braida, D
    Pozzi, M
    Parolaro, D
    Sala, M
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 413 (2-3) : 227 - 234
  • [4] CP 55,940 protects against ischemia-induced electroencephalographic flattening and hyperlocomotion in Mongolian gerbils
    Braida, D
    Pozzi, M
    Sala, M
    [J]. NEUROSCIENCE LETTERS, 2000, 296 (2-3) : 69 - 72
  • [5] Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide
    Di Marzo, V
    Breivogel, C
    Bisogno, T
    Melck, D
    Patrick, G
    Tao, Q
    Szallasi, A
    Razdan, RK
    Martin, BR
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 406 (03) : 363 - 374
  • [6] Endovanilloid signaling in pain
    Di Marzo, V
    Blumberg, PM
    Szallasi, A
    [J]. CURRENT OPINION IN NEUROBIOLOGY, 2002, 12 (04) : 372 - 379
  • [7] Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues
    Di Marzo, V
    Lastres-Becker, I
    Bisogno, T
    De Petrocellis, L
    Milone, A
    Davis, JB
    Fernandez-Ruiz, JJ
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 420 (2-3) : 123 - 131
  • [8] Hampson AJ, 2000, ANN NY ACAD SCI, V899, P274, DOI 10.1111/j.1749-6632.2000.tb06193.x
  • [9] Putative neuroprotective actions of N-acyl-ethanolamines
    Hansen, HS
    Moesgaard, B
    Petersen, G
    Hansen, HH
    [J]. PHARMACOLOGY & THERAPEUTICS, 2002, 95 (02) : 119 - 126
  • [10] CANNABINOL AND CANNABIDIOL IN COMBINATION - TEMPERATURE, OPEN-FIELD ACTIVITY, AND VOCALIZATION
    HILTUNEN, AJ
    JARBE, TUC
    WANGDAHL, K
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1988, 30 (03) : 675 - 678